Drug Shortage Report for ANANDRON

Last updated on 2024-05-17 History
Report ID 204346
Drug Identification Number 02221861
Brand name ANANDRON
Common or Proper name nilutamide
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH
Market Status MARKETED
Active Ingredient(s) NILUTAMIDE
Strength(s) 50MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size Box of 90 tablets
ATC code L02BB
ATC description HORMONE ANTAGONISTS AND RELATED AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2023-09-18
Actual start date
Estimated end date
Actual end date 2024-05-16
Shortage status Resolved
Updated date 2024-05-17
Company comments The product will be discontinued due to manufacturing issues
Health Canada comments
Tier 3 Status No
Contact Address ZIEGELHOF 24
GREIFSWALD, MECKLENBURG - WEST POMERANIA
GERMANY 17489
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2024-05-17 English Compare
v14 2024-05-16 French Compare
v13 2024-05-16 English Compare
v12 2024-05-16 English Compare
v11 2023-11-18 French Compare
v10 2023-11-18 English Compare
v9 2023-11-18 French Compare
v8 2023-11-18 English Compare
v7 2023-10-05 French Compare
v6 2023-10-05 English Compare
v5 2023-10-04 French Compare
v4 2023-10-04 English Compare
v3 2023-09-19 English Compare
v2 2023-09-14 French Compare
v1 2023-09-14 English Compare

Showing 1 to 15 of 15